|
Volumn 8, Issue 2, 2010, Pages 57-59
|
Adjuvant bisphosphonates in breast cancer: The ABCSG-12 study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANASTROZOLE;
ANTINEOPLASTIC AGENT;
BISPHOSPHONIC ACID DERIVATIVE;
ESTROGEN;
GOSERELIN;
PROGESTERONE RECEPTOR;
TAMOXIFEN;
ZOLEDRONIC ACID;
ADJUVANT THERAPY;
ANTINEOPLASTIC ACTIVITY;
BONE DENSITY;
BONE METASTASIS;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER HORMONE THERAPY;
CANCER PREVENTION;
CANCER RECURRENCE;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
DISTANT METASTASIS;
DRUG EFFECT;
DRUG EFFICACY;
DRUG FATALITY;
DRUG MECHANISM;
DRUG POTENCY;
DRUG TARGETING;
HORMONE RESPONSE;
HUMAN;
JAW OSTEONECROSIS;
NEPHROTOXICITY;
NOTE;
OUTCOME ASSESSMENT;
OVERALL SURVIVAL;
PREMENOPAUSE;
RADIATION INJURY;
TREATMENT DURATION;
|
EID: 77955983146
PISSN: 15441873
EISSN: 15442241
Source Type: Journal
DOI: 10.1007/s11914-010-0012-5 Document Type: Note |
Times cited : (7)
|
References (4)
|